CYTENA launches C.STATION, a fully automated platform for stable cell line development to streamline production of antibody and gene therapies
Today CYTENA, a BICO company, launched C.STATION, a new platform for fully automated stable cell line development. The platform combines CYTENA’s already proven single cell dispensing technology along with its best-in-class liquid handling expertise to enable affordable and high-quality laboratory automation. This combination of technologies advances BICO’s Bio Convergence agenda and democratizes access to production of next generation healthcare solutions including antibody therapies, gene therapies, and biosimilar production. “C.STATION is a key step in advancing the Bio Convergence
The staff innovation competition supports Kiilto’s extensive research and development work. This year’s winning proposition is a service that helps to speed up bonding and ensure its quality.This year’s Kiilto Up innovation competition was won by a service concept where the drying process of bonding layered structures is monitored using a sensor.
The leader of the winning team, Head of RDI for Industrial Adhesives Soilikki Kotanen, who works in Kiilto's product development, says that the solution can significantly speed up bonding processes.
“The sensor tells us exactly when the
